Leo Pharma, awaiting FDA approval decision, finds dermatologists are frustrated with current chronic hand eczema treatments
A new survey commissioned by Leo Pharma confirms that there’s plenty of room in the market for its chronic hand eczema treatment Anzupgo, which is currently under review by the FDA.
A new survey commissioned by Leo Pharma confirms that there’s plenty of room in the market for its chronic hand eczema treatment Anzupgo, which is currently under review by the FDA.
